Table Of Content

Clinica Chimica Acta 248 (1996) 213-214 Author index Volume 248 (1996) Alvarez, J.J., see Iglesias, A. 248, 157 in early stage cholestatic liver disease before Arranz, M., see Iglesias, A. 248, 157 and during treatment with ursodeoxycholic acid 248, 175 Banba, T., see Sakumoto, H. 248, 205 Froissart, R., see Piraud, M. 248, 143 Bernard, A., see Piraud, M. 248, 143 Bofil, P., see Jabor, A. 248, 99 Galatola, G., see Fracchia, M. 248, 175 Boran, G., R. O’Moore, W. Grimson, M. Peters, Garcia-Beltran, L., see Pelegri, M.D. 248, 65 A. Hasman, T. Groth, F. Van Merode, A new Grimaud, J.-A., see Ricard-Blum, S. 248, 187 clinical laboratory information system Grimson, W., see Boran, G. 248, 19 architecture from the OpenLabs project Groth, T., see Boran, G. 248, 19 offering advanced services for laboratory Gruson, A., see de Graeve, J.S. 248, 39 staff and users 248, 19 Guerret, S., see Ricard-Blum, S. 248, 187 Braams-Wiatrowska, J.K., see Steijns, Guez, A., I. Nevo, Neural networks and fuzzy L.S.W. 248, 135 logic in clinical laboratory computing with application to integrated monitoring 248, Cambus, J.P., see de Graeve, J.S. 248, 39 73 Cheesmar, R., see Hooper, J. 248, 119 Chevallier, M., see Ricard-Blum, S. 248, 187 Hasman, A., see Boran,G. 248, 19 Chossegros, P., see Ricard-Blum, S. 248, 187 Herrera, E., see Iglesias, A. 248, 157 Connelly, D.P., B.H. Sielaff, K.E. Willard, The Hofmann, A.F., see Fracchia, M. 248, 175 clinical workstation as a means of improving Hooper, J., J. O'Connor, R. Cheesmar, Learning laboratory use 248, 5! clinical biochemistry using multimedia inter- Crosignani, A., see Fracchia, M. 248, 175 active clinical cases 248, 119 de Graeve, J.S., J.P. Cambus, A. Gruson, P.M. Ighesias, A., M. Arranz, J.J. Alvarez, J. Perales, Valdigui¢, Automated technical validation — J. Villar, E. Herrera, M.A. Lasuncién, Cho- a real time expert system for decision sup- lesteryl ester transfer activity in liver disease port 248, 39 and cholestasis, and its relation with fatty Dudukina, T.V., see Tsvetkova, 1.V. 248, 125 acid composition of lipoprotein lipids 248, 157 Eguchi, Y., see Sakumoto, H. 248, 205 Jabor, A., T. Vik, P. Bofil, Introduction of a new Farnan, L.P., see Wells, 1.G. 248, 31 laboratory test: an econometric approach Ferraris, R., see Fracchia, M. 248, 175 with the use of neural network analysis 248, Fracchia, M., K.D.R. Setchell, A. Crosignani, 9 M. Podda, N. O'Connell, R. Ferraris, A.F. Hofmann, G. Galatola, Bile acid conjugation Karpova, E.A., see Tsvetkova, 1.V. 248, 125 0009-8981/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 214 Author index vol. 248 (1996) Koch, M., R. Lehmann, M. Pfohl, W. Voelter, carboxy-terminal cross-linked telopeptide of H. Liebich, Analysis of the deletion/insertion type I collagen (ICTP) is a potential serum polymorphism of the angiotensin I-convert- marker of ongoing liver fibrosis 248, 187 ing enzyme gene by capillary electrophoresis Roomi, M.W., C.S. Tsao, Effect of ascorbic acid 248, 197 deficiency on plasma prothrombin time and partial thromboplastin time in guinea Lasuncién, M.A., see Iglesias, A. 248, 157 pigs 248, 209 Lehmann, R., see Koch, M. 248, 197 Liebich, H., see Koch, M. 248, 197 Sakumoto, H., Y. Terada, R. Tabata, Y. Eguchi, Luiting, H.-J., see Steijns, L.S.W. 248, 135 O. Takehiro, S. Uno, T. Banba, K. Ozawa, Ketone body ratios of capillary blood com- Maire, I., see Piraud, M. 248, 143 pared with that of arterial blood 248, 205 Mandon, G., see Piraud, M. 248, 143 Seiffert, U.B., see Regeniter, A. 248, 107 Setchell, K.D.R., see Fracchia, M. 248, 175 Neuberger, J., M. Peters, The clinical interface — Siede, W.H., see Regeniter, A. 248, 107 a British Physician's view 248, 11 Sielaff, B.H., see Connelly, D.P. 248, 5! Nevo, I., see Guez, A. 248, 73 Solberg, H.E. The CCL conferences revisited 248, 3 O'Connell, N., see Fracchia, M. 248, 175 Steijns, L.S.W., J.K. Braams-Wiatrowska, H.-J. O'Connor, J., see Hooper, J. 248, 119 Luiting, J. van der Weide, Evaluation of O’Moore, R., see Boran, G. 248, 19 nonisotopic binding assays for measuring Ozawa, K., see Sakumoto, H. 248, 205 vitamin B,> and folate in serum 248, 135 Pascual, C., see Pelegri, M.D. 248, 65 Tabata, R., see Sakumoto, H. 248, 205 Pelegri, M.D., L. Garcia-Beltran, C. Pascual, Takehiro, O., see Sakumoto, H. 248, 205 Improvement of emergency and routine Terada, Y., see Sakumoto, H. 248, 205 turnaround time by data processing and in- Trepo, C., see Ricard-Blum, S. 248, 187 strumentation changes 248, 65 Tsao, C.S., see Roomi, M.W. 248, 209 Perales, J., see Iglesias, A. 248, 157 Tsvetkova, I.V., E.A. Karpova, T.V. Dudukina, Peters, M., see Boran, G. 248, 19 Y.V. Voznyi, 4-Pentafluoroethylumbellifery|- Peters, M., see Neuberger, J. 248, 11 B-p-glucoside as a new fluorogenic substrate Pfohl, M., see Koch, M. 248, 197 for acid 8-D-glucosidase 248, 125 Piraud, M., R. Froissart, G. Mandon, A. Ber- nard, I. Maire, Amniotic fluid for screening Uno, S., see Sakumoto, H. 248, 205 of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops Valdiguié, P.M., see de Graeve, J.S. 248, 39 fetalis) 248, 143 van der Weide, J., see Steijns, L.S.W. 248, 135 Podda, M., see Fracchia, M. 248, 175 Van Merode, F., see Boran, G. 248, 19 Villar, J., see Iglesias, A. 248, 157 Rayment, M.W., see Wells, 1.G. 248, 31 Vik, T., see Jabor, A. 248, 99 Regeniter, A., W.H. Siede, U.B. Seiffert, Compu- Voelter, W., see Koch, M. 248, 197 ter assisted interpretation of laboratory test Voznyi, Y.V., see Tsvetkova, 1.V. 248, 125 data with ‘MDI-LabLink’ 248, 107 Reibnegger, G., H. Wachter, Self-organizing Wachter, H., see Reibnegger, G. 248, 91 neural networks — an alternative way of clus- Wells, 1.G., L.P. Farnan, M.W. Rayment, ter analysis in clinical chemistry 248, 91 Clienv/Server computing: is this the future Ricard-Blum, S., P. Chossegros, S. Guerret, C. direction for the clinical laboratory? 248, 31 Trepo, J.-A. Grimaud, M. Chevallier, The Willard, K.E., see Connelly, D.P. 248, 51 Clinica Chimica Acta 248 (1996) 215-218 Subject index Volume 248 (1996) Amniotic fluid; Non-immune hydrops fetalis; Capillary blood; Arterial ketone body ratio; Lysosomal storage disorder; Screening 248, 143 Ketone body; Arteriovenous anastomosis 248, 205 Analyser monitoring; Quality control; Proficiency testing; Mean of normals; Expert system 248, Capillary clectrophoresis; Angiotensin |- 39 converting enzyme; Deletion/insertion polymorphism 248, 197 Anesthesia; Neural networks; Expert systems; Pattern recognition; Monitors integration; Smart Carboxy-terminal telopeptide of type | collagen alarms; Medical informatics; Critical care; Pa- (ICTP), Type | collagen; Liver; Fibrosis; Serum tient monitoring 248, 73 marker 248, 187 Cholehepatic shunting; Primary biliary cirrhosis; Angiotensin I-converting enzyme; Deletion/inser- Primary sclerosing cholangitis; unconjugated bile tion polymorphism; Capillary electrophoresis acids; Cholestasis; Ursodeoxycholic acid; Bile 248, 197 acid conjugation efficiency 248, 175 Arterial ketone body ratio, Ketone body; Capil- Cholestasis; Cholestery! ester transfer protein; lary blood; Arteriovenous anastomosis 248, 205 Lipoproteins; Fatty acid composition; Liver disease 248, 157 Arteriovenous anastomosis; Arterial ketone body Cholestasis; Primary biliary cirrhosis; Primary ratio; Ketone body; Capillary blood 248, 205 sclerosing cholangitis; unconjugated bile acids; Cholehepatic shunting; Ursodeoxycholic acid; Ascorbic acid; Prothrombin time; Partial throm- Bile acid conjugation efficiency 248, 175 boplastin time; Guinea pigs 248, 209 Cholestery! ester transfer protein, Lipoproteins; Assessment; Education; Computer-aided learn- Fatty acid composition; Liver disease; ing; Multimedia; Interactive; Data interpreta- Cholestasis 248, 157 tion; Decision-making 248, 119 Client/server architecture; Laboratory informa- Bile acid conjugation efficiency, Primary biliary tion system; Graphical user interface; Object- cirrhosis; Primary sclerosing cholangitis; uncon- oriented design; Ethernet network 248, 31 jugated bile acids; Cholestasis; Cholehepatic shunting; Ursodeoxycholic acid 248, 175 Clinical laboratory; Computing 248, 3 Blood transfusion; Laboratories; Practice Clinical laboratory services; OpenLabs project; guidelines; Physicians; Information systems; Laboratory information systems; Electronic data Computers; Expert system 248, 5! interchange 248, 19 0009-898 1/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 216 Subject index vol. 248 (1996) Cloned enzyme donor immunoassay (CEDIA); Laboratory information systems; Clinical labora- Microparticle enzyme immunoassay (MEIA); tory services 248, 19 lon capture (IC); Intermethod comparison 248, 135 Ethernet network; Client/server architecture; Laboratory information system; Graphical user Cluster analysis; Neural networks; Connectionist interface; Object-oriented design 248, 31 models; Self-organizing learning schemes; Un- supervised learning schemes 248, 91 Expert system; Interpretative reporting; Knowledge-based system; Laboratory data Computer-aided learning; Education; Multi- handling; Laboratory data visualisation; Inter- media; Interactive; Data interpretation; pretation of lactate dehydrogenase isoen- Decision-making; Assessment 248, 119 zymes 248, 107 Computers; Laboratories; Practice guidelines; Expert system; Laboratories; Practice guidelines; Blood transfusion; Physicians; Information Blood transfusion; Physicians; Information sys- systems; Expert system 248, 51 tems; Computers 248, 51 Computing; Clinical laboratory 248, 3 Expert system; Quality control; Proficiency testing; Mean of normals; Analyser monitor- Connectionist models; Neural networks; Cluster ing 248, 39 analysis; Self-organizing learning schemes; Un- supervised learning schemes 248, 91 Expert systems; Neural networks; Pattern recognition; Monitors integration; Smart alarms; Critical care; Neural networks; Expert systems; Medical informatics; Anesthesia; Critical care; Pattern recognition; Monitors integration; Smart Patient monitoring 248, 73 alarms; Medical informatics; Anesthesia; Patient monitoring 248, 73 Fatty acid composition; Cholesteryl ester transfer protein; Lipoproteins; Liver disease; Data interpretation; Education; Computer-aided Cholestasis 248, 157 learning; Multimedia; Interactive; Decision- making; Assessment 248, 119 Fibrosis; Type I collagen; Carboxy-terminal telopeptide of type I collagen (ICTP); Liver; Decision-making; Education; Computer-aided Serum marker 248, 187 learning; Multimedia; Interactive; Data interpretation; Assessment 248, 119 Fluorigenic substrate, 8-Glucosidase; Gaucher's disease 248, 125 Deletion/insertion polymorphism; Angiotensin I-converting enzyme; Capillary electrophoresis Gaucher’s disease; §8-Glucosidase; Fluorigenic 248, 197 substrate 248, 125 Diagnostic test; Simulation; Neural networks; 8-Glucosidase; Fluorigenic substrate; Gaucher’s Economy 248, 99 disease 248, 125 Economy; Simulation; Neural networks; Diag- Graphical user interface; Client/server architec- nostic test 248, 99 ture; Laboratory information system; Object- oriented design; Ethernet network 248, 31 Education; Computer-aided learning; Multi- media; Interactive; Data interpretation; Guinea pigs; Ascorbic acid; Prothrombin time; Decision-making; Assessment 248, 119 Partial thromboplastin time 248, 209 Efficient patient care; Hospital clinician; Labora- Hospital clinician; Laboratory specialist; Effi- tory specialist; Patient bed-stay 248, 11 cient patient care; Patient bed-stay 248, 11 Electronic data interchange; OpenLabs project; Information systems; Laboratories; Practice Subject index vol. 248 (1996) 217 guidelines; Blood transfusion; Physicians; Com- Laboratory information systems; OpenLabs pro- puters; Expert system 248, 5! ject; Electronic data interchange; Clinical laboratory services 248, 19 Interactive; Education; Computer-aided learning; Multimedia; Data interpretation; Decision- Laboratory specialist; Hospital clinician; Effi- making; Assessment 248, 119 cient patient care; Patient bed-stay 248, |! Intermethod comparison; Microparticle enzyme Lipoproteins; Cholesteryl ester transfer protein; immunoassay (MEIA); lon capture (IC); Cloned Fatty acid composition; Liver disease; enzyme donor immunoassay (CEDIA) 248, 135 Cholestasis 248, 157 Interpretation of lactate dehydrogenase isoen- Liver; Type 1 collagen; Carboxy-terminal zymes; Interpretative reporting; Expert system; telopeptide of type I collagen (ICTP); Fibrosis; Knowledge-based system; Laboratory data Serum marker 248, 187 handling; Laboratory data visualisation 248, 107 Liver disease; Cholesteryl ester transfer protein; Lipoproteins; Fatty acid composition; Interpretative reporting, Expert system; Cholestasis 248, 157 Knowledge-based system; Laboratory data handling; Laboratory data visualisation; Inter- Lysosomal storage disorder; Amniotic fluid; Non- pretation of lactate dehydrogenase isoen- immune hydrops fetalis; Screening 248, 143 zymes 248, 107 Mean of normals; Quality control; Proficiency lon capture (IC); Microparticle enzyme immuno- testing; Analyser monitoring; Expert system assay (MEIA); Cloned enzyme donor immuno- 248, 39 assay (CEDIA); Intermethod comparison 248, 135 Medical informatics; Neural networks; Expert systems, Pattern recognition; Monitors integra- Ketone body; Arterial ketone body ratio; Capil- tion; Smart alarms; Anesthesia; Critical care; lary blood; Arteriovenous anastomosis 248, Patient monitoring 248, 73 205 Micropeanzrymet iimmcunloasesa y (MEIA), lon Knowledge-based system; Interpretative report- capture (IC); Cloned enzyme donor im- ing, Expert system; Laboratory data handling; munoassay (CEDIA); Intermethod com- Laboratory data visualisation; Interpretation of parison 248, 135 lactate dehydrogenase isoenzymes 248, 107 Monitors integration; Neural networks; Expert Laboratories; Practice guidelines; Blood transfu- systems; Pattern recognition; Smart alarms; sion; Physicians; Information systems; Com- Medical informatics; Anesthesia; Critical care; puters; Expert system 248, 51 Patient monitoring 248, 73 Laboratory data handling; Interpretative reporting, Expert system; Knowledge-based system; Multimedia; Education; Computer-aided learn- Laboratory data visualisation; Interpretation of ing, Interactive; Data interpretation; Decision- lactate dehydrogenase isoenzymes 248, 107 making; Assessment 248, 119 Laboratory data visualisation; Interpretative Neural networks; Connectionist mode!s; Cluster reporting; Expert system; Knowledge-based sys- analysis; Self-organizing learning schemes, Un- tem; Laboratory data handling; Interpretation of supervised learning schemes 248, 91 lactate dehydrogenase isoenzymes 248, 107 Neural networks; Expert systems; Pattern recog- Laboratory information system; Client/server nition; Monitors integration; Smart alarms; architecture; Graphical user interface; Object- Medical informatics; Anesthesia; Critical care; oriented design; Ethernet network 248, 31 Patient monitoring 248, 73 218 Subject index vol. 248 (1996) Neural networks; Simulation; Economy; Diag- Quality assurance; Turnaround time; Stat test; nostic test 248, 99 Routine test 248, 65 Non-immune hydrops fetalis; Amniotic fluid; Quality control; Proficiency testing; Mean of nor- Lysosomal storage disorder; Screening 248, 143 mals; Analyser monitoring; Expert system 248, 39 Object-oriented design; Client/server architecture; Laboratory information system; Graphical user Routine test; Turnaround time; Quality assur- interface; Ethernet network 248, 31 ance; Stat test 248, 65 OpenLabs project; Laboratory information sys- Screening; Amniotic fluid; Non-immune hydrops tems; Electronic data interchange, Clinical labo- fetalis; Lysosomal storage disorder 248, 143 ratory services 248, 19 Self-organizing learning schemes; Neural net- Partial thromboplastin time; Ascorbic acid; Pro- works; Connectionist models; Cluster analysis; thrombin time; Guinea pigs 248, 209 Unsupervised learning schemes 248, 91 Patient bed-stay; Hospital clinician; Laboratory Serum marker; Type I collagen; Carboxy- specialist; Efficient patient care 248, 11 terminal telopeptide of type I collagen (ICTP); Liver; Fibrosis 248, 187 Patient monitoring; Neural networks; Expert systems; Pattern recognition; Monitors integration; Simulation; Neural networks; Economy; Diag- Smart alarms; Medical informatics; Anesthesia; nostic test 248, 99 Critical care 248, 73 Smart alarms; Neural networks; Expert systems; Pattern recognition; Neural networks; Expert sys- Pattern recognition; Monitors integration; Medi- tems; Monitors integration; Smart alarms; Medi- cal informatics; Anesthesia; Critical care; Patient cal informatics; Anesthesia; Critical care; Patient monitoring 248, 73 monitoring 248, 73 Stat test; Turnaround time; Quality assurance; Physicians; Laboratories; Practice guidelines; Routine test 248, 65 Blood transfusion; Information systems; Com- puters; Expert system 248, 51 Turnaround time; Quality assurance; Stat test; Routine test 248, 65 Practice guidelines; Laboratories; Blood transfusion; Physicians; Information systems; Com- Type I collagen; Carboxy-terminal telopeptide of puters; Expert system 248, 51 type I collagen (ICTP); Liver; Fibrosis; Serum marker 248, 187 Primary biliary cirrhosis; Primary sclerosing cholangitis; unconjugated bile acids; Cholestasis; Unconjugated bile acids; Primary biliary cirrhosis; Cholehepatic shunting; Ursodeoxycholic acid; Primary sclerosing cholangitis; Cholestasis; Bile acid conjugation efficiency 248, 175 Cholehepatic shunting; Ursodeoxycholic acid; Bile acid conjugation efficiency 248, 175 Primary sclerosing cholangitis; Primary biliary cirrhosis; unconjugated bile acids; Cholestasis; Unsupervised learning schemes; Neural networks; Cholehepatic shunting; Ursodeoxycholic acid; Connectionist models; Cluster analysis; Self- Bile acid conjugation efficiency 248, 175 organizing learning schemes 248, 91 Proficiency testing; Quality control; Mean of Ursodeoxycholic acid; Primary biliary cirrhosis; normals; Analyser monitoring; Expert system Primary sclerosing cholangitis; unconjugated bile 248, 39 acids; Cholestasis; Cholehepatic shunting; Bile acid conjugation efficiency 248, 175 Prothrombin time; Ascorbic acid; Partial thromboplastin time; Guinea pigs 248, 209 S T O i es BOrs hae )